Literature DB >> 20385224

T lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury.

Dominika Labuz1, Anja Schreiter, Yvonne Schmidt, Alexander Brack, Halina Machelska.   

Abstract

Neuropathic pain is a debilitating consequence of nerve injuries and is frequently resistant to classical therapies. T lymphocytes mediate adaptive immune responses and have been suggested to generate neuropathic pain. In contrast, in this study we investigated T cells as a source of opioidergic analgesic β-endorphin for the control of augmented tactile sensitivity following neuropathy. We employed in vivo nociceptive (von Frey) testing, flow cytometry and immunofluorescence in wild-type and mice with severe combined immunodeficiency (SCID) subjected to a chronic constriction injury of the sciatic nerve. In wild-type mice, T lymphocytes constituted approximately 11% of all immune cells infiltrating the injury site, and they expressed β-endorphin and receptors for corticotropin-releasing factor (CRF), an agent releasing opioids from leukocytes. CRF applied at the nerve injury site fully reversed neuropathy-induced mechanical hypersensitivity in wild-type animals. In SCID mice, T cells expressing β-endorphin and CRF receptors were absent at the damaged nerve. Consequently, these animals had substantially reduced CRF-mediated antinociception. Importantly, the decreased antinociception was fully restored by transfer of wild-type mice-derived T lymphocytes in SCID mice. The re-established CRF antinociception could be reversed by co-injection of an antibody against β-endorphin or an opioid receptor antagonist with limited access to the central nervous system. We propose that, in response to CRF stimulation, T lymphocytes accumulating at the injured nerves utilize β-endorphin for activation of local neuronal opioid receptors to reduce neuropathy-induced mechanical hypersensitivity. Our findings reveal β-endorphin-containing T cells as a crucial component of beneficial adaptive immune responses associated with painful peripheral nerve injuries.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385224     DOI: 10.1016/j.bbi.2010.04.001

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  25 in total

Review 1.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

2.  Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism.

Authors:  Scott Edwards; Leandro F Vendruscolo; Joel E Schlosburg; Kaushik K Misra; Sunmee Wee; Paula E Park; Gery Schulteis; George F Koob
Journal:  Neuropharmacology       Date:  2011-11-23       Impact factor: 5.250

3.  Interleukin-4 Induces the Release of Opioid Peptides from M1 Macrophages in Pathological Pain.

Authors:  Dominika Labuz; Melih Ö Celik; Viola Seitz; Halina Machelska
Journal:  J Neurosci       Date:  2021-02-16       Impact factor: 6.167

Review 4.  T Cells as Guardians of Pain Resolution.

Authors:  Annemieke Kavelaars; Cobi J Heijnen
Journal:  Trends Mol Med       Date:  2021-01-08       Impact factor: 11.951

5.  Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

Authors:  Po-Kuan Chao; Kwok-Tung Lu; Yun-Lin Lee; Jin-Chung Chen; Hung-Li Wang; Yi-Ling Yang; Mei-Yun Cheng; Ming-Feng Liao; Long-Sun Ro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

6.  T cell transgressions: Tales of T cell form and function in diverse disease states.

Authors:  Kevin M Harris; Madison A Clements; Andrew J Kwilasz; Linda R Watkins
Journal:  Int Rev Immunol       Date:  2021-06-21       Impact factor: 5.078

7.  Positive Long-Term Effects of Third Molar Extraction on Taste Function.

Authors:  Dane Kim; Richard L Doty
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 4.985

8.  Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation.

Authors:  Reine-Solange Sauer; Dagmar Hackel; Laura Morschel; Henrike Sahlbach; Ying Wang; Shaaban A Mousa; Norbert Roewer; Alexander Brack; Heike L Rittner
Journal:  Mol Pain       Date:  2014-02-06       Impact factor: 3.395

9.  μ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in mice.

Authors:  Yvonne Schmidt; Claire Gavériaux-Ruff; Halina Machelska
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

10.  Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions.

Authors:  Katerina S Iwaszkiewicz; Jennifer J Schneider; Susan Hua
Journal:  Front Pharmacol       Date:  2013-10-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.